The Philadelphia Inquirer reported today that the University of Pennsylvania’s gene therapy program has signed a lease for 150,000 square feet at Discovery Labs, the former GlaxoSmithKline campus just outside West Conshohocken in Upper Merion Township.

From the article:

Penn’s gene therapy program will use the space at the former Montgomery County pharmaceutical plant for part of its expanding research into genetic medicines for rare diseases, including ultra-rare ailments known as “orphan” diseases, as well as infectious diseases such as COVID-19, according to a release on Tuesday by Penn Medicine and MLP Ventures, which owns the property.

The article also goes into the growing need for lab space in the region and how Discovery Labs is poised to fill that need.

You can find the full article here.